🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jonathan H. Schatz

University of Miami

ORCID: 0000-0003-1842-228X

Also affiliated with Sylvester Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas”.

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Blood(2021)10.1182/blood.2021013379

N/A

4.9DataRank · unranked

180 citations

Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more

A network of RNA-binding proteins controls translation efficiency to activate anaerobic metabolism

Nature Communications(2020)10.1038/s41467-020-16504-1

N/A

0.628DataRank · unranked

65 citations

Nathan C. Balukoff, Phaedra R. Theodoridis, Miling Wang, Jonathan R. Krieger, Jonathan H. Schatz +2 more

Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax

Blood Cancer Journal(2025)10.1038/s41408-025-01214-y

N/A

0.345DataRank · unranked

9 citations

Dhanvantri Chahar, Marianna Lekakis, Abdessamad A. Youssfi, Lingxiao Li, Evan Roberts +10 more

Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline

BioDrugs(2025)10.1007/s40259-025-00735-z

N/A

0.345DataRank · unranked

9 citations

Asaad Trabolsi, Artavazd Arumov, Jonathan H. Schatz, Toral Shastri

Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2258244

N/A

0.269DataRank · unranked

5 citations

Caroline A. Coughlin, Asaad Trabolsi, Jonathan H. Schatz, Austin D. Newsam

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma

Blood(2022)10.1182/blood.2021015008

N/A

0DataRank · unranked

87 citations

Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla Reid +11 more

MATRIX platform to analyze translation machinery remodeling in glioblastoma cells

STAR Protocols(2022)10.1016/j.xpro.2022.101919

N/A

0DataRank · unranked

1 citations

Tyler A. Cunningham, Jonathan R. Krieger, Jonathan H. Schatz, Stephen Lee, J.J.David Ho

Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive Inhibitors

ACS Omega(2021)10.1021/acsomega.1c02805

N/A

0DataRank · unranked

7 citations

Tyler A. Cunningham, Christopher J. Zerio, Eli Chapman, Jonathan H. Schatz, Stephan C. Schürer +1 more

Data from Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors

(2023)10.1158/0008-5472.c.6512452

N/A

0DataRank · unranked

0 citations

Piumi Y. Liyanage, Asaad Trabolsi, Evan R. Roberts, Lingxiao Li, Braulio C.L.B. Ferreira +9 more

Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas

Blood Cancer Journal(2024)10.1038/s41408-024-00997-w

N/A

0DataRank · unranked

101 citations

Artavazd Arumov, Jonathan H. Schatz, Asaad Trabolsi

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.15.623836

N/A

0DataRank · unranked

0 citations

Dhanvantri Chahar, Michael D. Jain, Alexandra M. Poos, Michael Durante, Bachisio Ziccheddu +19 more

Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors

Cancer Research(2021)10.1158/0008-5472.can-20-2674

N/A

0DataRank · unranked

26 citations

Piumi Y. Liyanage, Asaad Trabolsi, Evan R. Roberts, Lingxiao Li, Braulio C.L.B. Ferreira +9 more

A translational program that suppresses metabolism to shield the genome

Nature Communications(2020)10.1038/s41467-020-19602-2

N/A

0DataRank · unranked

15 citations

J.J.David Ho, Phaedra R. Theodoridis, Miling Wang, Michael Bokros, Lis M. Llanio +4 more

187 | MUTATIONAL BCL10 ACTIVATION COOPERATES WITH BCL6 IN DLBCL LYMPHOMAGENESIS FACILITATING SUBTYPE‐SPECIFIC PRECISION IN VIVO MODELING

Hematological Oncology(2025)10.1002/hon.70094_187

N/A

0DataRank · unranked

0 citations

Karen S. Fernández, Caroline A. Coughlin, Haiwen Huang, Abdessamad A. Youssfi, Marianna Lekakis +6 more

Racial and clinical determinants of response in 2304 large B-cell lymphomas treated with CD19 CAR T in clinical trials

Blood Advances(2025)10.1182/bloodadvances.2025016361

N/A

0DataRank · unranked

0 citations

Sheila S. Diamond, Pénélope Lafeuille, Jonathan H. Schatz, Francesco Maura, Jacob Aptekar +2 more